Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: EyeDrMike who wrote (3787)	12/16/1997 10:47:00 PM
From: blankmind	Respond to of 23519

-I'm re-listening to the confer call. Not sure if the following 2 points were covered on here: 1. Reason for "late" announcement of sales shortfall: the process is such that yields are not known for a while - after the lab results come back - but test results will be more quickly found in the new facility - when the lab facilities will be on-site 2. Were as many as 17k new prescriptions per week. Now, it's a steady 10,000 new scrips per week. This is on top of refills. Out.